ArticleOncotarget2018

Pretreatment monocyte counts and neutrophil counts predict the risk for febrile neutropenia in patients undergoing TPF chemotherapy for head and neck squamous cell carcinoma.

Marie Shimanuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.